Pfizer and
its German partner BioNTech SE (BNTX) may have been the first, and others may be next. Apart from Moderna, Britain's AstraZeneca plc (LON: AZN) and Johnson & Johnson (NYSE: JNJ) may report positive results for their efforts in the upcoming week.
Pfizer's announcement came on the same day as Novavax, Inc. (NVAX stock) also announced progress in its covid immunization project.